Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/LA/New Orleans
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in New Orleans, LA

Studies commonly pay $75 to $4,500 per completed study

553 clinical trials are currently recruiting participants within 30 miles of New Orleans. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

553studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near New Orleans right now

Top 25 of 553 recruiting studies, sorted by proximity — each links to its official registry page

Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair

Hiatal Hernia N/A Interventional 200 participants sought
Louisiana State University School of Medicine — New Orleans, Louisiana (11.8 mi) · Sponsor: Weill Medical College of Cornell University
See eligibility & contact on ClinicalTrials.gov (NCT06444347)

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

Focal Onset Seizures Phase 2 Interventional 216 participants sought
Ochsner Clinic Foundation — New Orleans, Louisiana (11.8 mi) · Sponsor: Supernus Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06798896)

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes N/A Observational 200 participants sought
Tulane University — New Orleans, Louisiana (11.8 mi) · Sponsor: Jaeb Center for Health Research
See eligibility & contact on ClinicalTrials.gov (NCT06837181)

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Prostate Cancer Phase 3 Interventional 940 participants sought
East Jefferson Hospital — Metairie, Louisiana (14.6 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06855277)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — New Orleans, Louisiana (11.8 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Breast Neoplasms, Triple Negative Breast Neoplasms Phase 3 Interventional 2,400 participants sought
Ochsner Clinic Foundation ( Site 0021) — New Orleans, Louisiana (11.8 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06966700)

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Breast Cancer Phase 3 Interventional 400 participants sought
University Medical Center New Orleans — New Orleans, Louisiana (11.8 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07062965)

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

Multiple Myeloma Phase 3 Interventional 893 participants sought
East Jefferson General Hospital — Metairie, Louisiana (14.6 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT05020236)

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Childhood Medulloblastoma Phase 3 Interventional 225 participants sought
Children's Hospital New Orleans — New Orleans, Louisiana (11.8 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT05382338)

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Phase 3 Interventional 428 participants sought
Louisiana State University Health Science Center — New Orleans, Louisiana (11.8 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05646316)

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation Phase 1 Interventional 420 participants sought
Ochsner MD Anderson Cancer Center — Jefferson, Louisiana (15.2 mi) · Sponsor: Kura Oncology, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05735184)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
Ochsner Clinic Foundation — New Orleans, Louisiana (11.8 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate Phase 2 Interventional 1,431 participants sought
GI Alliance - Gastro Group and Endocenter - Mandeville — Mandeville, Louisiana (21.6 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07415044)

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Overweight , Obesity, Adults Phase 2 Interventional 220 participants sought
BRCR Global Louisiana — Gretna, Louisiana (13.0 mi) · Sponsor: Alveus Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07837973)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Tulane University School of Medicine — New Orleans, Louisiana (11.8 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2

Post Operative Surgical Site Infection Phase 3 Interventional 600 participants sought
LSU Health Sciences — New Orleans, Louisiana (11.8 mi) · Sponsor: Major Extremity Trauma Research Consortium
See eligibility & contact on ClinicalTrials.gov (NCT04678154)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Malignant Glioma Phase 1, Phase 2 Interventional 132 participants sought
Children's Hospital New Orleans — New Orleans, Louisiana (11.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05099003)

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Metabolic Dysfunction-Associated SteatoHepatitis (MASH) Phase 2 Interventional 120 participants sought
Tandem Clinical Research — Metairie, Louisiana (14.6 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05519475)

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

Diffuse Cutaneous Systemic Sclerosis Phase 2 Interventional 200 participants sought
UMC New Orleans — New Orleans, Louisiana (11.8 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06470048)

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

Refractory Metastatic Colorectal Cancer Phase 2 Interventional 90 participants sought
Ochsner Clinic Foundation — New Orleans, Louisiana (11.8 mi) · Sponsor: Delcath Systems Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06607458)

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Type 2 Diabetes, Cortisol Excess Phase 2 Interventional 1,500 participants sought
Tulane University School of Medicine — New Orleans, Louisiana (11.8 mi) · Sponsor: Sparrow Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07296484)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
Louisiana State University Health Science Center — New Orleans, Louisiana (11.8 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Randomized Clinical Trial of Re-Evaluating Suicidal Thoughts in Veterans

Suicidal Ideation, Suicide, Attempted N/A Interventional 180 participants sought
Southeast Louisiana Veterans Health Care System, New Orleans, LA — New Orleans, Louisiana (11.8 mi) · Sponsor: VA Office of Research and Development
See eligibility & contact on ClinicalTrials.gov (NCT05884476)

Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors

Solid Tumor Phase 1 Interventional 105 participants sought
Ochsner Clinic Foundation — New Orleans, Louisiana (11.8 mi) · Sponsor: ImmunoGenesis
See eligibility & contact on ClinicalTrials.gov (NCT06014502)
Actively enrolling

Studies you may be able to join near New Orleans

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in New Orleans

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

DelRicht Research | Clinical Trials in New Orleans, Louisiana

★ 4.8
3525 Prytania St 612, 412, 308, New Orleans, LA 70115
(504) 336-2667
"I’ve been part of a few clinical trials at Delricht and I’ve always had a good experience. The staff is friendly, they’re very careful (I have small …"
— Margie Perez, 5★

Tulane Center for Clinical Research

1440 Canal St #1700, New Orleans, LA 70112
(504) 988-0200

Louisiana Cancer Research Center

★ 5.0
1700 Tulane Ave, New Orleans, LA 70112
(504) 210-1591
"They have a Great spine and Neurological Regeneration Program, I've been told By Multiple sources. We are here to put it to the test 🛡 😍 💉"
— Wade Anthony Cadman, 5★

Velocity Clinical Research

★ 4.8
3308 Tulane Ave Ste 600, New Orleans, LA 70119
(504) 304-7197
"It was a little tricky to find a there's no clear signage on the building, especially on parking. Google Maps tells you to turn but it looks like a o…"
— Elizabeth, 5★

Clinical Trials in Gretna, Louisiana | DelRicht Research

★ 5.0
315 Westbank Expy b, Gretna, LA 70053
(504) 336-2667

Tandem Clinical Research

★ 4.5
1151 Barataria Blvd Ste 3200, Marrero, LA 70072
(504) 934-8424

Clinical Trials Management

★ 4.8
3801 Houma Blvd Unit 200, Metairie, LA 70006
(504) 455-1310
"I was happy at first. I was told that the weekly diary was $10 a week completed once a week.<br>I did this for six months and received a $70 check at…"
— Verna Selander, 2★

Smart Trials – Clinical Research Center

4 Hawkins Ave, Jefferson, LA 70121
(504) 300-8308

Best Clinical Trial

★ 5.0
3600 Prytania St #71, New Orleans, LA 70115
(504) 897-5211
"Excellent Clinical Trials operations facility and service. They treat their patients with care and are efficient with their studies."
— Stephen Truxillo, 5★

Clinical trials in New Orleans: what's recruiting

The New Orleans area currently has 553 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to New Orleans, the most active research areas are:

  • Cancer & Oncology14 studies
  • Diabetes & Metabolism4 studies
  • Heart & Vascular1 studies
  • Immune & Skin1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from New Orleans, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in New Orleans

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

New Orleans participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in New Orleans?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in New Orleans safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in New Orleans, LA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in New Orleans?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in New Orleans?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of New Orleans.

Paid clinical trials near New Orleans

Other metros within reach

Metairie, LA522 Gulfport, MS37 Baton Rouge, LA221 Mobile, AL174 Lafayette, LA60 Jackson, MS226 Pensacola, FL137 Lake Charles, LA28

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in New Orleans Severe Chronic Pruritus in New Orleans Chronic Kidney Disease (HealthMatch) in New Orleans Bladder Issues Due To Spinal Cord Injury in New Orleans All conditions

More of LA

Metairie522 Baton Rouge221 Shreveport158 Lafayette60 Lake Charles28

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts